A high-dose aminoglycoside regimen combined with renal replacement therapy for the treatment of MDR pathogens: a proof-of-concept study — Alexandre Brasseur (2016) | RDL Network
A high-dose aminoglycoside regimen combined with renal replacement therapy for the treatment of MDR pathogens: a proof-of-concept study
Article 2016 en
Authors
AB
Alexandre Brasseur
MH
Maya Hites
SR
Sandrine Roisin
Abstract
1 min read
In this cohort of septic patients with MDR GN infections, HDA combined with high-flow CVVHDF represented a valuable therapeutic option. The effectiveness of this approach should be further evaluated in larger studies.
Fabio Silvio Taccone, Pierre‐François Laterre, Herbert Spapen, Thierry Dugernier, Isabelle Delattre, Brice Layeux, Daniel De Backer, Xavier Wittebole, Pierre Wallemacq, Jean Louis Vincent, Frédérique Jacobs
Discussion(0)
No comments yet. Be the first to comment.